pubrio
Botanix Pharmaceuticals

Botanix Pharmaceuticals

Australia · Pharmaceuticals

Pharmaceuticals

Botanix Pharmaceuticals (ASX:BOT) is a clinical stage dermatology company developing novel treatments for common skin diseases and infection leveraging its novel delivery technology, Permetrex™. We have attracted a world-class team and significant capital to support the progression of our products. We are moving quickly, but never at the expense of our rigorous commitment to ethical research and development (R&D) and the highest clinical standards mandated by the US Food and Drug Administration (FDA). Our goal is to unlock the true potential of synthetic cannabinoids for people around the world, with an evidence-first approach.

Company Insights
Company Overview

1984

Founded

Pharmaceuticals

Industry

Australia

Location

115,324,584

Ranking

11 employees

Size

Similar Companies

Get full access to view complete information

Frequently Asked Questions Regarding Botanix Pharmaceuticals

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​